<DOC>
	<DOCNO>NCT00775697</DOCNO>
	<brief_summary>In study child recurrent wheeze ( &gt; /= 2 episode last 6 month ) age less 2 year enrol outpatient . They undergo lung function evaluation Rint assessment flow curve baseline 4 week treatment Montelukast 4 mg/day . Symptom dairy fill parent study period .</brief_summary>
	<brief_title>Montelukast Children With Wheezing</brief_title>
	<detailed_description>Patients age less 2 year recurrent wheezing . At visit 1 patient symptom enrol study explain . They return home bronchodilator therapy . Within 1 week return visit 2 start run-in period bronchodilator prn fill dairy symptom drug use . Skin prick test evaluate time . At visit 3 1 week run-in period start therapy Montelukast 4 mg 4 week , use bronchodilator prn fill diary . The final visit four week re-evaluation lung function</detailed_description>
	<mesh_term>Respiratory Sounds</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<mesh_term>Leukotriene Antagonists</mesh_term>
	<criteria>Age 624 month Patients recurrent wheeze ( least 2 episode last 6 month ) Patients symptoms enrollment Chronic respiratory disease ( cystic fibrosis , chronic lung disease ) symptoms visit 1 require hospital admission</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>24 Months</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>wheeze</keyword>
	<keyword>child</keyword>
	<keyword>montelukast</keyword>
	<keyword>bronchodilator</keyword>
	<keyword>lung function</keyword>
	<keyword>Rint</keyword>
</DOC>